Researchers from the Radboudumc and Radboud University will partner with social organisations to map how often young people with mild intellectual disabilities have psychological problems and how they can be treated. The project was recently awarded a subsidy of 1.5 million euro by ZonMw.
So far, little research has been carried out for and with young people with mild intellectual disabilities. That is why more research that looks into psychological problems in this group is urgently needed. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) describes a mild intellectual disability as a ‘neurobiological developmental disorder in which there are limitations in intellectual and self-reliant functioning’.
No reliable figuresThere are no reliable figures in the Netherlands on the number of young people with this diagnosis. Additionally, hardly any information is available about the risk and protective factors that influence their functioning, despite the fact that there are large, leading population studies and clinical cohorts in the Netherlands with suitable data to gain insight into this.
In this new project, researchers will bundle and analyse data from these studies. They will use the results to optimize treatment and monitor patients with an innovative, person-oriented method: the iamYu app. iamYu is currently competing for the 2019 medical inspiration prize.
Joint initiativeThe project application was awarded the subsidy under the ZonMw grant call titled 'Long-term cohort study into early recognition and treatment in mental health care'. The project is a joint initiative of the Academic Workplace Kayak (in particular Dr. Mariëlle Dekker and Dr. Wouter Groen), main applicant Prof. Roy Otten (Radboud University, Pluryn), project leader Dr. Nanda Rommelse (Radboudumc, Karakter) , co-project leader Dr Catharina Hartman (UMCG), the aforementioned clinical institutions and leading population studies, and interest groups Zorgbelang Inclusive, LFB, and patient association KansPlus.
Related news items
HFSP Grant for Johannes Textor30 March 2020
Johannes Textor, theme Cancer development and immune defense, has been awarded a program grant of 1 million US dollars by The Human Frontier Science Program (HFSP) to investigate how T cells navigate extremely dense environments using experiments, modeling and methods from pedestrian dynamics.read more
Ritalin enhances your ability to do tasks by making you more motivated26 March 2020
A new study uncovers how stimulants like Ritalin work in the brain, and it challenges some misconceptions for its recreative use. The collaboration between Radboudumc and Brown University (USA) was published in the journal Science.read more
Dealing with COVID-19 in low- and middle-income countries26 March 2020
RIHS researcher Joost Hopman believes that low-and middle-income countries should intensify their preparedness for a possible COVID-19 outbreak. This was the core message of an opinion article that he wrote at the request of the medical journal JAMA.read more
Physiotherapy is important to the recovery of patients with the coronavirus26 March 2020
Patients who have been infected with the coronavirus and admitted to the hospital for this reason should receive physiotherapy as soon as their condition allows. This is the view expressed by physiotherapists and researchers from the Radboudumc in a set of joint treatment recommendations.read more
Healthcare utilization and regional variation of end-of-life hospital care in Dutch cancer patients26 March 2020
In International Journal of Quality Health Care RIHS researcher Femke Atsma showed high healthcare utilization and medical variation in End of Life care in Cancer patients, which was not associated with GP care or long term care.read more